371 top medical experts on Palmoplantar Keratoderma across 59 countries and 21 U.S. states, including 194 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Palmoplantar Keratoderma: Group of mostly hereditary disorders characterized by thickening of the palms and soles as a result of excessive keratin formation leading to hypertrophy of the stratum corneum (hyperkeratosis).
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Keratosis (2,394), Genetic Skin Diseases (3,548) and Narrower Categories: Diffuse Palmoplantar Keratoderma (190), Papillon-Lefevre Disease (379).
  4. Clinical Trials ClinicalTrials.gov : at least 3 including 1 Completed, 1 Recruiting
  5. Synonyms: Hyperkeratosis Palmaris et Plantaris,  Keratosis Palmaris et Plantaris,  Palmoplantar Keratosis,  Meleda Disease


  

        

                    


    Computing Expert Listing ...

);